Viewing Study NCT02771795


Ignite Creation Date: 2025-12-24 @ 2:09 PM
Ignite Modification Date: 2026-02-02 @ 12:18 AM
Study NCT ID: NCT02771795
Status: TERMINATED
Last Update Posted: 2024-02-02
First Post: 2016-05-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC
Sponsor: Samsung Bioepis Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 View
None Trastuzumab View
None Biosimilar View
None Cancer View
None Breast View
None Positive View